1. Home
  2. SVM vs VIR Comparison

SVM vs VIR Comparison

Compare SVM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$9.49

Market Cap

2.5B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.37

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
VIR
Founded
N/A
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.5B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
SVM
VIR
Price
$9.49
$9.37
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$10.50
$19.63
AVG Volume (30 Days)
4.6M
4.4M
Earning Date
02-09-2026
05-06-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$36.87
N/A
Revenue Next Year
$35.34
$1,049.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.15
$4.16
52 Week High
$14.00
$10.91

Technical Indicators

Market Signals
Indicator
SVM
VIR
Relative Strength Index (RSI) 35.76 56.02
Support Level $6.15 $8.67
Resistance Level $11.48 $10.29
Average True Range (ATR) 0.65 0.58
MACD -0.36 -0.09
Stochastic Oscillator 14.07 42.28

Price Performance

Historical Comparison
SVM
VIR

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: